Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ATM S1905Ifs25 + STK11 K262Sfs25

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

STK11 deletion + KRAS mutation (6)

ATM deletion + SF3B1 mutation (4)

CPS1 overexpression + KRAS mutation + STK11 mutation (3)

Chr del(11q) + ATM mutation (2)

STK11 mutation + TMB-H (2)

ATM expression + ATM T2333fs* + EGFR negative (1)

BRCA2 deletion + ATM mutation (1)

KRAS G12C + PD-L1 underexpression + STK11 mutation (1)

KRAS mutation + STK11 mutation + AXL expression (1)

PD-L1 deletion + STK11 mutation (1)

PD-L1 expression + STK11 mutation (1)

PD-L1 expression + STK11 mutation + JAK2 mutation (1)

STK11 deletion + TMB-H (1)

STK11 deletion + TTF1 positive (1)

STK11 mutation + KRAS mutation + TP53 deletion (1)

STK11 mutation + TMB-H + PD-L1 overexpression (1)

STK11 deletion + KRAS mutation (6)

ATM deletion + SF3B1 mutation (4)

CPS1 overexpression + KRAS mutation + STK11 mutation (3)

Chr del(11q) + ATM mutation (2)

STK11 mutation + TMB-H (2)

ATM expression + ATM T2333fs* + EGFR negative (1)

BRCA2 deletion + ATM mutation (1)

KRAS G12C + PD-L1 underexpression + STK11 mutation (1)

KRAS mutation + STK11 mutation + AXL expression (1)

PD-L1 deletion + STK11 mutation (1)

PD-L1 expression + STK11 mutation (1)

PD-L1 expression + STK11 mutation + JAK2 mutation (1)

STK11 deletion + TMB-H (1)

STK11 deletion + TTF1 positive (1)

STK11 mutation + KRAS mutation + TP53 deletion (1)

STK11 mutation + TMB-H + PD-L1 overexpression (1)

›

ATM S1905Ifs*25 + STK11 K262Sfs*25

Gallbladder Cancer

Sensitive: C4 – Case Studies

Sensitive: C4 – Case Studies